Erythema Multiforme Following Hepatitis A and Pneumococcal Vaccinations

Area of Science:

• Immunology
• Dermatology
• Pediatric Medicine

Background:

• Erythema multiforme (EM) is a rare, cell-mediated immune response.
• It characteristically presents as symmetrical target lesions on extremities.
• EM is typically self-limited, resolving within 5 weeks, with rare prodromal symptoms.

Purpose of the Study:

• To report an association between Erythema multiforme and recent vaccination.
• To highlight potential vaccine-associated adverse events in pediatric populations.

Main Methods:

• Case study analysis.
• Review of clinical presentation and vaccination history.

Main Results:

• The patient developed Erythema multiforme following administration of the hepatitis A and pneumococcal vaccines.
• The presentation was consistent with typical EM morphology and distribution.

Conclusions:

• Vaccination, specifically with hepatitis A and pneumococcal vaccines, may be a trigger for Erythema multiforme.
• Further investigation into vaccine-associated EM is warranted, particularly in pediatric patients.